VIRTUAL

O Instituto de Pós-Graduação em Medicina (PIM) exige que os professores, planejadores e outros que controlam o conteúdo educacional divulguem todas as suas relações financeiras com empresas inelegíveis.  Todos os conflitos de interesse identificados são minuciosamente investigados e mitigados de acordo com a política do PIM.  A existência ou ausência de COI para todos aqueles em condições de controlar o conteúdo educacional será divulgada aos participantes antes do início de cada atividade.

Miguel Albanese
Consulting fees from AbbVie
Fees for Non-CE services from Mead Laboratories

Daniel Aletaha
Consulting fees from AbbVie, Amgen, Lilly, Merck, Novartis, Pfizer, Roche and Sandoz
Research support from AbbVie, Amgen, Lilly, Novartis, Roche, SoBi and Sanofi

Ana Maria Arredondo Gonzalez
Consulting fees from Janssen and Bristol Meyers Squibb
Fees for Non-CE services from Janssen, Bristol Meyers Squibb, Pfizer, Biopas, Amgen Roche and Lilly

Cecelia Asnal
Consulting fees from Pfizer, Lilly and Abbvie

Joshua Baker
Consulting fees from Bristol Myers Squibb, Burns-White, LLC, Pfizer and CorEvitas

Alejandro Balsa
Consulting fees from Pfizer, Roche, Abbvie, BMS, UCB, MSD, Novartis, Nordic, Sandoz, Kern Pharma, Sanofi, Gilead, Galapagos
Fees for Non-CE services from Pfizer, Roche, Abbvie, BMS, UCB, MSD, Novartis, Nordic, Sandoz, Kern Pharma, Sanofi, Gilead, Galapagos

Wilson Bautista-Molano
Consulting fees from Lilly, Novartis and Pfizer

Mihai Bojinca
Consulting fees from Lilly, Novartis and Pfizer
Fees for Non-CE services from AbbVie, Lilly, Novartis, Pfizer, Sandoz, Krka and Zentiva

Antonio Cachafeiro
Consulting fees from AbbVie, Novartis and Sandoz

Juan Canoso
Royalty from UpToDate (2 chapters)

Loreto Carmona
Contracted research with AbbVie, Gebro Pharma, MSD, Novartis, Pfizer, Roche, Sanofi Aventis, Gruenthal and UCB

Gustavo Citera
Consulting fees from Pfizer, Eli Lilly, Janssen, Abbvie, Amgen and Sandoz

Ines Corbacho
Consulting fees from AbbVie and Scienza

Maria de Los Angeles Correa
Consulting fees from AbbVie and Janssen

Carmen de Cunto
Speaker fees from Biogen, Springer Educational Program
Contracted research fees from Clementia/Ipsen

Cristina Drenkard
Consulting fees from SLE Expert Network
Contracted research fees from Let’s Talk About Lupus Education Program

Doruk Erkan
Royalty from UpToDate
Consulting fees from UCB, Alexion
Fees for Non-CE services from GSK, Aurinia
Contracted research fees from ACR/Eular, NIH, GSK, Exagen, LCTC

Polly Ferguson
Consulting fee from Novartis

Ivan Foeldvari
Contracted research fees to be part of the Phase III nintdeanib study for jSSc

Richard Furie
Consulting fees from GlaxoSmithKline, Aurinia Pharmaceuticals

Adrian Gaser
Consulting fees from Boehringer Ingelheim
Fees for Non-CE services from Boehringer Ingelheim, Biotoscana, Raffio and Bagó

Annelise Goecke
Consulting fees from Janssen, AbbVie, BMS and UCB

Jose Gomez Puerta
Consulting fees from Sanofi and Galápagos
Fees for Non-CE services from AbbVie, Astra Zeneca, BMS, Lilly, GSK, MSD, Pfizer, Roche

Ellen Gravallese
Salary from NEJM for Associate Editor position; Salary from ACR for Presidency and President Elect positions
Royalty from textbook “Rheumatology” and UpToDate

Kristen Hayward
Ownership Interest less than 5% in Abbott Labs, AbbVie, Avanos Medical Inc, Teva Pharmaceuticals
Ownership Interest greater than 5% in Merck

Johanna Hernandez
Consulting fees from Pfizer and AbbVie

Sebastian Herrera Uribe
Consulting fees from Janssen-Cilag, Novartis, Amgen, Bristol Myers Squibb and AbbVie
Fees for Non-CE services from Pfizer, Roche, AbbVie, Janssen-Cilag, Novartis, Amgen and Bristol Myers Squibb

Frederic Houssiau
Consulting fees from GSK, Idorsia and Astra Zeneca

Annamaria Iagnocco
Consulting fees from
AbbVie, MSD, Alfasigma, Celltrion, BMS, Celgene, Eli Lilly, Sanofi Genzyme, Galapagos, Gilead, Novartis and Sobi Inc

Carolina Isnardi
Consulting fees from Bristol Myers Squibb
Contracted research fees from Pfizer, Elea Phoenix, AbbVie and Janssen

David Karp
Contracted research fees from Glaxo Smith Kline, Genentech, Bristol Myers Squibb, UCB Pharma, Eli Lilly and Celgene

Kim Lauper
Consulting fees from Pfizer, Celltrion, Viatris and Gilead-Galapagos

Carlos Lozada
Consulting fees from Pfizer, Aurinia, Novartis and Amgen

Claudia Marques
Consulting fees from Novartis and AbbVie

Iain McInnes
Consulting fees from AbbVie, Astra Zeneca, Amgen, BMS, Cabaletta, Causeway Therapeutics, Compugen, Eli Lilly, Gilead, GSK, Janssen, Novartis, Pfizer, Sanofi and UCB
Contracted research fees from BMS, Compugen, GSK, Eli Lilly, Janssen, Novartis, Pfizer and UCB
Ownership interest less than 5% in Causeway Therapeutics, Cabaletta and Compugen

Licia Mota
Consulting fees from Boehringer Ingelheim, AbbVie, Janssen, Pfizer and Amgen
Fees for Non-CE Services from AbbVie, Pfizer, Roche, Janssen, Boehringer Ingelheim and Sandoz

Jose Luis Neyro
Contracted research fees from Stada and Amgen

Eduardo S. Paiva
Consulting fees from Janssen and Amgen
Fee for Non-CE services from Pfizer

Guillermo Pons-Estel
Consulting fees from Pfizer and GSK
Fees for Non-CE services from Janssen, Pfizer and GSK
Contracted research fees from Janssen

Chris Ritchlin
Consulting fees from Amgen, AbbVie, UCB, Lilly, Janssen, Novartis, Bristol Myers Squibb and Sun

Brad Rovin
Consulting fees from Aurinia and GSK

Percival Sampaio
Consulting fees from Boehringer, Lilly, Novartis and Pfizer
Fees for Non-CE services from AbbVie, Boehringer, Lilly, Novartis and UCB

Pedro Santos-Moreno
Consulting fees from Boehringer, Lilly, Pfizer, Janssen, Novartis, Biopas-UCB
Fees for Non-CE services from Lilly, Pfizer, Janssen, Novartis, Amgen and Biopas-UCB
Contracted research fees from Janssen, Pfizer and Bristol Myers Squibb

Fernando Sommerfleck
Consulting fees from AbbVie and Janssen
Fees for Non-CE services from AbbVie, Janssen and Novartis

Enrique Soriano
Consulting fees from AbbVie, Amgen, Janssen, Lilly, Novartis and Pfizer
Fees for Non-CE services from AbbVie, Amgen, Janssen, Lilly, Novartis and Pfizer

Lilith Stange
Consulting fees from Novartis, Sandoz, Roche and AbbVie
Fees for Non-CE services from Fresenius Kabi, AbbVie, Roche, Pfizer, Novatis, Eurofarma and Biopas

Flavio Sztajnbok
Consulting fees from Novartis
Fees for Non-CE services from AbbVie, Alexion and Novartis

Teresa Terreri
Consulting fees from Novartis

Gloria Vasquez
Fees for Non-CE Services from AbbVie, Janssen and Roche

Dan Zhao
Royalty from UpToDate
Consulting fees from Novartis
Contracted research fees from BMS

Dina Arrieta
Consulting fees from AbbVie and Novartis

Cesar Pacheco
Consulting fees from AbbVie, Novartis and Eli Lilly
Contracted research fees for AbbVie, Eli Lilly and Pfizer

Juan Jose Scali
Consulting fees from AbbVie, Pfizer, Bago, Montpellier and TRB Pharma

Alejandro Nitsche
Medical Advisor at Bago Laboratories of Argentina

Luis Fernando Luque
Ownership interest greater than 5% in Adhera Health Inc (Co-founder and Chief Scientific Officer)

John Cush
Consulting fees from AbbVie, Novartis, BMS and Amgen

Carlos Enrique Toro Gutierrez
Consulting fees from Janssen, Roche, Novartis, Boehringer Ingelheim
Fees for Non-CE services from AbbVie and Biopas

Os demais membros nada têm a declarar.